Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Koblenz
Clinical trial register · Germany

Clinical Trials in Koblenz, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC5 Loxo Oncology, Inc.2 Bristol-Myers Squibb2 Hoffmann-La Roche2 Christian Buske2
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Koblenz

32 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Takeda
Phase 3
324
Freiburg im Breisgau, Heidelberg, Mutlangen, Minden, Koblenz, Chemnitz, Halle, Jena
2026-09-10
Recruiting
BeOne Medicines
Phase 3
1,056
Koblenz
2026-05-22
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Essen, Dessau, Hamburg, Hanover, Heidelberg, Koblenz, Langen, München
2026-05-21
Recruiting
GlaxoSmithKline
Phase 2
200
Frankfurt, Hamburg, Karlsruhe, Koblenz, München
2026-04-15
Recruiting
Bristol-Myers Squibb
Phase 3
850
Augsburg, Erlangen, Koblenz, Ludwigshafen am Rhein, Magdeburg, Kiel, Jena, Berlin
2026-03-16
Recruiting
BioNTech SE
Phase 3
558
Augsburg, Bremen, Frankfurt, Freiburg im Breisgau, Gera, Hamburg, Koblenz, Mannheim
2025-10-30
Recruiting
Pfizer
Phase 3
714
Ulm, Gröbenzell, Traunstein, Giessen, Kassel, Koblenz, Chemnitz, Halle
2025-07-23
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Paraplatin
Merck Sharp & Dohme LLC
Phase 3
2,400
Erlangen, Munich, Paderborn, Koblenz, Saarbrücken, Berlin
2025-06-30
Recruiting
Hoffmann-La Roche
Phase 3
450
Cologne, Dresden, Essen, Hamburg, Hanover, Heidelberg, Koblenz, Langen
2025-04-09
Recruiting
Christian Buske
Phase 2
80
Bielefeld, Chemnitz, Kempten, Kiel, Koblenz, Landshut, Mönchengladbach, Mutlangen
2025-03-21
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Cologne, Frankfurt, Göttingen, Hanover, Hösbach, Koblenz
2025-01-03
Active, closed
Regeneron Pharmaceuticals
Phase 4
120
Augsburg, Munich, Frankfurt am Main, Koblenz, Lübeck, Berlin, Leipzig, Mainz
2024-08-26
Active, closed
Celgene
Phase 3
850
Ulm, Augsburg, Bayreuth, Erlangen, Langen, Hanover, Koblenz, Halle
2024-06-19
Active, closed
Novartis Pharmaceuticals
Observational
116
Hamburg, Lingen, Koblenz, Leipzig, Halle, Ahaus, Berlin, Bremen
2024-06-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Esslingen am Neckar, Regensburg, Hemer, Koblenz, Leipzig, Halle, Bad Berka, Gera
2024-04-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Ulm, Landshut, Mönchengladbach, Koblenz, Halle, Berlin
2023-12-13
Active, closed
Bristol-Myers Squibb
Phase 3
402
Erding, Münster, Koblenz, Leipzig, Jena, Berlin, Düsseldorf, Lübeck
2023-10-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
614
Mannheim, Kempten (Allgäu), Würzburg, Koblenz, Halle, Berlin
2023-02-06
Recruiting
University of Leipzig
Phase 2
213
Berlin, Bonn, Cottbus, Erlangen, Greifswald, Hamburg, Kassel, Koblenz
2022-09-27
Recruiting
INSIGHTFUL-FFR Clinical Trial
NCT05437900Coronary Artery Disease, Acute Coronary Syndrome
CoreAalst BV
Phase 4
2,500
Dresden, Fürth, Herford, Koblenz, Lahr, Mainz
2022-09-22
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Aachen, Berlin, Dresden, Greifswald, Hamburg, Koblenz, Mainz
2022-04-11
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Ulm, Würzburg, Giessen, Münster, Koblenz, Mainz, Lübeck, Hamburg
2021-04-08
Recruiting
Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C
NCT05035693Discopathy, Herniated Cervical Disc, Stenoses, Spinal, Radiculopathy
NGMedical GmbH
Not applicable
170
Berlin, Gelnhausen, Itzehoe, Koblenz, München, Würselen
2021-03-11
Active, closed
Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty
NCT04618016Osteoarthritis, Knee, Arthritis, Rheumatoid, Intra-Articular Fractures, Joint Instability
Aesculap AG
Observational
605
Bünde, Koblenz, Berlin, Eisenberg, Reinbek, Rostock
2021-03-08
Active, closed
C. R. Bard
Not applicable
477
Hamburg, Berlin, Heidelberg, Koblenz
2019-12-12
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Mainz, Kiel, Koblenz, München, Offenbach/ Main
2019-10-02
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
588
Koblenz
2019-05-20
Active, closed
Obinutuzumab in Marginal Zone Lymphoma
NCT03322865Marginal Zone Lymphoma
DrugObinutuzumab
Christian Buske
Phase 2
56
Bochum, Essen, Freiburg im Breisgau, Göttingen, Halle, Koblenz, Mainz, Mannheim
2018-11-23
Active, closed
Gilead Sciences
Phase 2
502
Duisburg, Frankfurt, Freiburg im Breisgau, Hamburg, Heidelberg, Herne, Jena, Koblenz
2018-08-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Esslingen am Neckar, Immenhausen, Düsseldorf, Hemer, Rheine, Koblenz, Dresden, Leipzig
2018-04-24
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
420
Dresden, Berlin, Düsseldorf, Essen, Hamburg, Heidelberg, Koblenz, Marburg
2015-08-06
Recruiting
C-Brace Prospective Registry
NCT04640584Pareses, Lower Extremity
Otto Bock Healthcare Products GmbH
Observational
250
Traunstein, Göttingen, Hanover, Koblenz
2015-04
Rows per page Showing 1–32 of 32
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/koblenz

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 32 of those studies with a site in Koblenz.

How many clinical trials are recruiting in Koblenz?

18 of the 32 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 14 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Koblenz), 32 studies
PhaseStudiesRecruitingShare
Phase 317953.1%
Phase 26418.8%
Not applicable329.4%
Observational319.4%
Phase 4216.3%
Phase 2/3113.1%

Most active sponsors

Lead sponsors with the most studies (Koblenz)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC53
Bristol-Myers Squibb21
Christian Buske21
Hoffmann-La Roche22
Loxo Oncology, Inc.21
Aesculap AG10
Alliance for Clinical Trials in Oncology10
BeOne Medicines11
BioNTech SE11
C. R. Bard10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.